Organon was a pharmaceutical company headquartered in Oss, Netherlands. In November 2007, Schering-Plough Corporation, based in New Jersey, USA, acquired Organon, active pharmaceutical ingredient producer Diosynth (separate from Organon until 2004), and its veterinary pharmaceutical sister company Intervet ...
Organon International B.V. company research & investing information. Find executives and the latest company news.
Organon is a Dutch pharmaceutical company started in Oss the Netherlands. It is famous for "the Pil" a birthcontrol pil. Organon grew as a company and was taken over by Schering plough and later on by Merck and continues as MSD in the Netherlands. In the old days the compant was great, it used to be "gezellig" !
Government contends a price reduction is the only discount exception to the Anti- Kickback Statute; PhRMA says this interpretation puts companies at risk of criminal liability for other discount arrangements. Legal Issues Reimbursement. Bookmark. 12 Sep 2016 ...
Organon International's detailed financings; Comprehensive pipeline breakdown, including molecular targets & partnerships. 17 years of in-depth BioPharma industry analysis.
... the company's ability to accurately predict future market conditions; manufacturing difficulties or delays; financial instability of international economies and sovereign risk; dependence on the effectiveness of the company's patents and other protections for innovative products; and the exposure to litigation, including patent ...
Get information, directions, products, services, phone numbers, and reviews on Organon International in Roseland, NJ. Discover more Pharmaceutical Preparations companies in Roseland on Manta.com.
May 30, 2008 ... ... review of the acquisition by Schering‑Plough Corporation ("Schering‑Plough") of Organon BioSciences N.V. ("Organon") from Akzo Nobel N.V. ("Akzo") (" proposed transaction"). Akzo is based in the Netherlands and is the parent company to Organon. This was an international transaction that involved the ...
Mar 12, 2007 ... on today's announcement, Akzo Nobel CEO Hans Wijers said: “The intended sale of Organon BioSciences is a major milestone in the history of Akzo Nobel. It is a fundamental step towards our goal of creating a focused, international industrial player. At the same time, we are convinced that we have found ...